Mr. George Emont is an Angel Investor. He serves as Board Member at Intrepid Bioinformatics. Mr. Emont served as Managing Partner at Kentucky Seed Capital Fund. He was a Managing Partner with the Kentucky Seed Capital Fund and a Venture Partner with Triathlon Medical Ventures. Until 2003, Mr. Emont was Director of Venture Capital for Humana Inc. (NYSE: HUM), managing their $70 million venture portfolio. Mr. Emont was a co-founder of OncoTherapeutics, an early stage cancer immunotherapy company, which was sold to Biomira, Inc. As part of the IAI Venture Capital Group of Minneapolis, he evaluated and recommended new investment opportunities. Mr. Emont led the first round of financing of SangStat Medical Corporation and served on its Board of Directors prior to its going public and eventually being bought by Genzyme. Previously, Mr. Emont held positions within Baxter Healthcare. He holds an MBA in Finance and Marketing from the University of Chicago. Mr. Emont brings a diverse background in venture capital, business development and proven early stage company development expertise. He also served as Board Member at RhinoCyte.